Schering-Plough Afrin, Lotrimin GMP Shortcomings Cited In FDA-483 Report
This article was originally published in The Tan Sheet
Executive Summary
Batch validations at a Schering-Plough manufacturing site in Puerto Rico uncovered several problems related to Afrin nasal spray and Lotrimin antifungal, FDA-483 inspection reports show.